Why the study?
Low ADAMTS-13 and high VWF have been associated with cardiovascular disease and AF, but their relation along with TSP-1 to clinical outcomes remained to be investigated.
Are von Willebrand factor, ADAMTS-13, and thrombospondin 1 levels associated with clinical outcomes in elderly patients with a recent myocardial infarction?
Are von Willebrand factor, ADAMTS-13, and thrombospondin 1 levels associated with clinical outcomes in elderly patients with a recent myocardial infarction?
In elderly patients with a recent myocardial infarction, low ADAMTS-13 predicts death and low VWF is associated with new-onset atrial fibrillation, but their overall utility for predicting broad cardiovascular risk may be limited.
Answers are grounded in this paper and cite their sources.
May refine targeted post-MI risk assessment in elderly; leaves open broader prognostic utility given weaker associations.
Background: von Willebrand factor (VWF) multimers are cleaved by A disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13 (ADAMTS-13) into less active fragments. Thrombospondin 1 (TSP-1) competes with VWF's cleavage site, protecting it from degradation. Low ADAMTS-13 and high VWF have been associated with cardiovascular disease and atrial fibrillation (AF). Objectives: We aimed to investigate whether VWF, ADAMTS-13, and TSP-1 are associated with clinical outcome. Methods: Elderly patients with a recent myocardial infarction (MI) (n = 1027) were followed for 2 years. Blood was collected 2 to 8 weeks after the MI for ADAMTS-13, VWF, and TSP-1 measures. The primary endpoints (major adverse cardiovascular events; n = 210) included the first event of MI, stroke, heart failure hospitalization, coronary revascularization, and all-cause death. Total mortality was also registered (n = 56). The secondary endpoint was new-onset AF (n = 43). Results: = .04]), and this was still significant after adjustments. Conclusion: Although low ADAMTS-13 predicted death, the cardiovascular risk associated with VWF and ADAMTS-13 was weaker than previously reported. Low VWF is associated with new-onset AF and needs further research.
No takes yet. Share an insight, caveat, or question.
Warlo et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: